期刊
EPIGENOMICS
卷 12, 期 11, 页码 935-953出版社
FUTURE MEDICINE LTD
DOI: 10.2217/epi-2019-0352
关键词
AML; biomarker; circRNAs; CREBRF; hsa_circ_0001947; hsa-miR-329-5p; therapy
资金
- National Natural Science Foundation of China [91642110]
- Shandong Provincial Natural Science Foundation [ZR2018PH012]
Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML. Materials & methods: We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship. Results:hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis. Conclusion:hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据